(PDF) P027 Efficacy and Safety of Bevacizumab Combined With

P027 Efficacy and Safety of Bevacizumab Combined With Chemotherapy for Second - Line and Above in Non - Squamous Cell Lung Cancer

Journal of Thoracic Oncology - United States

doi 10.1016/j.jtho.2018.10.051

Full Text

Abstract

Available in full text

Categories

Respiratory Medicine

Date

December 1, 2018

Authors

Publisher

Elsevier BV

Related search

OA08 Efficacy and Safety of Sintilimab Combined With 1st Line Chemotherapy in Advanced Squamous Cell Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

Bevacizumab Combination Chemotherapy in Clinical Practice for Advanced Non-Squamous Non-Small Cell Lung Cancer

Japanese Journal of Lung Cancer

Respiratory Medicine

English

P3.01-94 Safety and Efficacy of First-Line Pemetrexed Versus Bevacizumab-Containing Regimens in Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

Anti-Pd-1 Therapy Plus Chemotherapy and/or Bevacizumab as Second Line or Later Treatment for Patients With Advanced Non-Small Cell Lung Cancer

Journal of Cancer

English

PCN37 Cost-Minimization Analysis of Second-Line Chemotherapy for Non-Small-Cell Lung Cancer (NSCLC)

Value in Health

Occupational Health

English

Efficacy and Safety of Apatinib Plus Vinorelbine in Patients With Wild-Type Advanced Non–Small Cell Lung Cancer After Second-Line Treatment Failure

JAMA network open

English

Efficacy and Safety of Icotinib as First-Line Therapy in Patients With Advanced Non-Small-Cell Lung Cancer

OncoTargets and Therapy

English

P106 the Efficacy and Safety of Bevacizumab Combined With Chemotherapy in the Treatment of Drug-Resistant SCLC

Journal of Thoracic Oncology

Respiratory Medicine

English

Safety and Effectiveness of Localized Lung Resection Combined With Neoadjuvant Chemotherapy in the Treatment of Stage I-Ii Non-Small Cell Lung Cancer

Oncology Letters

Cancer Research

English